The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: Substantial reduction in mortality and morbidity

Blood

Volumn 89, Issue 12, 1997, Pages 4393-4401

  Kessler, Craig M ^a,b   Tang, ZhaoCheng ^a   Jacobs, Helena M ^a   Szymanski, Linda M ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ENOXAPARIN; FIBRIN; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BLEEDING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; FIBRIN FORMATION; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030974615     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4393     Document Type: Article

References (28)

1. Blachman MA, Austin R, Femandez-Rachubinski F, Sheffield WP: Molecular basis of inherited human antithrombin deficiency. Blood 80:2159. 1992
2. Rosenberg RD, Damus PS: The purification and mechanism of action of human-antithrombin-heparin cofactor. J Biol Chem 248:6490, 1973
3. Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA: Thrombosis in antithrombin III deficient individuals: Report of a large kindred and literature review. Ann Intern Med 116:754, 1992
4. Jordan RE, Kilpatrick J, Nelson RM: Heparin promotes the inactivation of antithrombin by neutrophil elastase. Science 237:777, 1987
5. Jochum M, Lander S, Heimburger N, Fritz H: Effect of human granulocytic elastase on isolated human antithrombin III. HoppeSeyler's Z Physiol Chem 362:103, 1981
6. Mammen EF, Mijakawa T, Phillips TF, Assarian GS, Brown JM, Murano G: Human antithrombin concentrates and experimental disseminated intravascular coagulation. Semin Thromb Haemost 11:373, 1985
7. Fourrier F, Chopin C, Goudemand J, Hendryex S, Caron C, Rime A, Marey A, Lesteval P: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 101:816, 1992
8. 1-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation. Am J Clin Pathol 82:396, 1984
9. Emerson TE, Fournel MA, Leach WJ, Redens TB: Protection against disseminated intravascular coagulation and death by antithrombin III in the Escherichia coli endotoxemic rat. Circ Shock 21:1. 1987
10. Triantaphyllopoulous DC: Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemost 51:232, 1984
11. Taylor FB, Emerson TE, Jordan R, Chank AK, Blick KE: Antithrombin III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock 26:227, 1988
12. Dickneite G, Paques EP: Reduction of mortality with antithrombin III in septicemic rats: A study of Klebsiella pneumoniae induced sepsis. Thromb Haemost 69:98, 1993
13. Redens TB, Emerson TE: Antithrombin III treatment limits disseminated intra-vascular coagulation in endotoxemia. Circ Shock 28:49, 1989
14. Fourrier F, Chopin C, Huart J, Runge I, Caron C, Goudemand J: Double blind placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104:882, 1993
15. Vinazzer H: Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Semin Thromb Hemost 15:347, 1989
16. Jochum M: Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation. Semin Hematol 32:19, 1995
17. Kessler CM, Nussbaum E, Tuazon CU: In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. J Lab Clin Med 109:647, 1987
18. Kessler CM, Nussbaum E, Tuazon CU: Disseminated intravascular coagulation associated with Staphylococcus aureus septicemia is mediated by peptidoglycan-induced platelet aggregation. J Infect Dis 164:101, 1991
19. Clauss A: Gerinnungsphysiologische schnell methode zur bestimmung des fibrinogens. Acta Haematol 17:237, 1957
20. Minna JD, Robby SH, Colman RW: Disseminated Intravascular Coagulation in Man. Springfield, IL, Charles C. Thomas, 1974
21. Carvalho AC, Freeman NJ: How coagulation defects alter outcome in sepsis. J Crit Illness 9:51, 1994
22. Bick RL, Dukes ML, Wilson WL, Fekete LF: Antithrombin III as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 10:721, 1977
23. Blauhut B, Nacek S, Vinazzer H, Bergmann H: Substitution therapy with an antithrombin III concentrate in shock and DIC. Thromb Res 27:271, 1982
24. Blauhut B, Kramar H, Vinazzer H, Bergmann H: Substitution of antithrombin III in shock and DIC: A randomized study. Thromb Res 39:81, 1985
25. Wages D, Steprans I, Hambleton J, Bass NM, Corash L: Structural characterization and functional effects of a novel acquired heparan sulfate circulating anticoagulant. Blood 86:197a, 1995 (abstr, suppl 1)
26. Carrell RW, Owen MC: Plakalbumen, alpha-1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature 317:730, 1985
27. Redens TB, Leach WJ, Bogdanoff DA, Emerson TE: Synergistic protection from lung damage by combining antithrombin III and alpha-1-proteinase inhibitor in the E. coli endotoxaemic sheep pulmonary dysfunction model. Circ Shock 26:15, 1988
28. Drake TA, Pang M: Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis 157:749, 1988